DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1  (02-2018)

Period of time： 2018年S1期

Publisher： John Wiley & Sons Inc

Founded in： 1999

Total resources： 46

E-ISSN： 1463-1326|20|S1

ISSN： 1462-8902

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1

Menu

Issue Information

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 1-2

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Title Page Toc

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 3-4

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Incretin hormones: Their role in health and disease

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 5-21

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A review of GLP‐1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 22-33

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 34-46

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

What have we learnt from “real world” data, observational studies and meta‐analyses

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 47-58

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Incretins: Beyond type 2 diabetes

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 59-67

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Efficacy of glucagon‐like peptide‐1 receptor agonists compared to dipeptidyl peptidase‐4 inhibitors for the management of type 2 diabetes: A meta‐analysis of randomized clinical trials

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue S1 , Vol. 20, Iss. S1, 2018-02 , pp. 68-76

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Total 8 item(s)